CX3CL1 and Alzheimer disease: Microglial fractalkine signaling plays variable roles in different stages of AD pathogenesis in association with neuroinflammation, neurotoxicity, and synaptic plasticity (Chen et al., 2016; Zhang L. et al., 2018).